stockrowHumana Inc.
HUM Healthcare Healthcare Plans
Humana Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.7 billion, up 10.1% from fiscal 2024.
- Revenue
- +26.1%
- EPS
- −16.7%
- Free cash flow
- +158.7%
- Total debt
- −0.82%
Quarter to September 2026, against a year earlier
Follow HUM
Alert me
Humana Inc. (HUM) Total debt
Humana Inc.'s total debt at the end of fiscal 2025 was $12.4B, up 5.53% from $11.7B in fiscal 2024. At the end of the quarter to 30 September 2026 it was $12.5B. Over the past ten years it has ranged from $4.1B (fiscal 2016) to $12.5B (fiscal 2021); the current reading is higher than 91% of that period. Humana Inc. ranks 6th of 12 Healthcare Plans companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $12.4B | 5.53% |
| FY2024 | $11.7B | 0.56% |
| FY2023 | $11.7B | 4.76% |
| FY2022 | $11.1B | (10.95%) |
| FY2021 | $12.5B | 87.60% |
| FY2020 | $6.7B | 17.54% |
| FY2019 | $5.7B | (6.64%) |
| FY2018 | $6.1B | 23.35% |
| FY2017 | $4.9B | 20.23% |
| FY2016 | $4.1B | (0.02%) |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $12.5B | (12.23%) |
| Jun 2026 | $14.2B | 1.82% |
| Mar 2026 | $14.0B | 13.13% |
| Dec 2025 | $12.4B | (1.89%) |
| 43 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| UNH UnitedHealth Group Incorporated compare | $68.7B |
| CVS CVS Health Corporation compare | $60.7B |
| CI Cigna Group compare | $31.1B |
| ELV Elevance Health, Inc. compare | $30.8B |
| CNC Centene Corporation compare | $15.5B |
| HUM Humana Inc. | $12.5B |
| MOH Molina Healthcare, Inc compare | $4.0B |
| OSCR Oscar Health, Inc. compare | $432.4M |
| PGNY Progyny, Inc. compare | $19.5M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on HUM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement